Providence Alaska Medical Center will be the first in the state to offer Pluvicto, an innovative therapy for metastatic ...

A new research paper was published by Aging (Aging-US) on January 8, 2025, in Volume 17, Issue 1, titled "Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer ...

Jason Molitoris, MD, PhD, Associate Professor of Radiation Oncology at University of Maryland School of Medicine joins Alex to discuss the causes of head and ne ...

PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.

Burjeel Holdings has announced its plan to establish the leading radiation oncology network in the GCC, following its ...

If you are traveling, you might be asked to walk through a scanner. But are those scanners safe? Here's everything you need ...

OPTYX study shows many patients with advanced prostate cancer preferred oral relugolix over injectables for androgen deprivation therapy.

Cancer therapy has always struggled with targeting tumor cells effectively while minimizing damage to healthy tissue.

CINCINNATI (WKRC) — Mysta Bee, a young artist battling throat cancer, is advancing to the next phase of his treatment plan. Diagnosed after a mass on his neck left him unable to breathe, Mysta Bee, ...

A discovery of how to target mutated proteins in tumors made a decade ago never matured into a surefire way of destroying ...

John Ryan, a U.S. Navy veteran, beat cancer through nearly a decade of experimental immunotherapy treatment. The vet shared ...

CMRI researchers discovered that DNA repair pathways control how cancer cells die after radiotherapy. Blocking a key repair ...